Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children

BACKGROUND: Urinary schistosomiasis, the result of infection by Schistosoma haematobium (Sh), remains a major global health concern. A schistosome vaccine could represent a breakthrough in schistosomiasis control strategies, which are presently based on treatment with praziquantel (PZQ). We report t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS Negl Trop Dis
Главные авторы: Riveau, Gilles, Schacht, Anne-Marie, Dompnier, Jean-Pierre, Deplanque, Dominique, Seck, Modou, Waucquier, Nawal, Senghor, Simon, Delcroix-Genete, Delphine, Hermann, Emmanuel, Idris-Khodja, Noureddine, Levy-Marchal, Claire, Capron, Monique, Capron, André
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300301/
https://ncbi.nlm.nih.gov/pubmed/30532268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006968
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы